NSYS

Nortech Systems Inc. (NSYS) - Q2 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2026. Nortech Systems Inc. is a global Electronic Manufacturing Services (EMS) provider operating in the Medical Device, Medical Imaging, Aerospace and Defense, and Industrial markets. The company operates facilities in the United States (Minnesota), Mexico, and China. It is classified as a non-accelerated filer and a smaller reporting company.

Key Financial Metrics

Note: All figures in thousands except per share data and percentages. Total debt includes $7,868 in lines of credit and $2,068 in term loans (current and long-term portions).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9.3% in Q2 and 10.9% YTD compared to 2025. Growth was driven by the Medical Device (+36.0% Q2) and Medical Imaging (+12.2% Q2) sectors. Industrial and Aerospace/Defense sales declined in Q2 but showed YTD growth in Aerospace/Defense (+8.7%).
• Profitability: Gross margin expanded by 120 basis points in Q2 and 260 basis points YTD, attributed to higher revenue volumes and improved manufacturing cost absorption. However, operating income decreased 16.0% in Q2 due to higher selling and general/administrative expenses, primarily driven by increased incentive compensation accruals ($402k in Q2 2026 vs. a reversal of $131k in Q2 2025).
• Turnaround: The company returned to profitability YTD ($282k net income) compared to a net loss of $1,003k in the prior year, aided by the absence of restructuring charges that impacted Q1 2025.
• Backlog: Total order backlog increased 19.8% year-over-year to $93,849, driven largely by Aerospace and Defense orders.

Outlook, Risks, and Unusual Items

• Financing Restructuring: In March 2026, the company replaced its Bank of America facility with a new $15,000 revolving credit facility and $2,200 term loan from Associated Bank. The new facility matures in March 2029 and requires a Fixed Charge Coverage Ratio of 1.10 to 1.00. The company was in compliance as of June 30, 2026.
• Tariff Impact: Following a Supreme Court ruling in February 2026, IEEPA-based tariffs were terminated, but a temporary 10% global tariff was imposed under Section 122. In July 2026, new Section 301 tariffs (10%-12.5%) were implemented on imports from certain countries. Management is evaluating the impact on costs and pursuing refunds for previously paid tariffs, though no amounts have been recognized yet.
• Liquidity: Operating cash flow remains negative ($2,449k used YTD) due to significant increases in inventory ($3,530k used) and accounts receivable/contract assets ($4,500k used) to support growing backlog. Financing activities provided $2,774k YTD.
• Risks: Key risks include supply chain disruptions, raw material cost volatility (copper, oil), reliance on major customers (Customer A represents 30% of Q2 sales), and compliance with debt covenants dependent on EBITDA generation.

Investor Verification Checklist

• Debt Covenants: Verify the company's ability to maintain the 1.10 Fixed Charge Coverage Ratio under the new Associated Bank facility, especially given the negative operating cash flow.
• Inventory Levels: Assess the $24,512 inventory balance (up from $20,695 at year-end) to ensure it aligns with the $93.8M backlog and does not indicate obsolescence risks.
• Tariff Exposure: Monitor the outcome of tariff refund claims and the actual cost impact of the new Section 301 tariffs on the supply chain.
• Customer Concentration: Review the stability of "Customer A," which accounts for 30% of Q2 sales and 26% of accounts receivable.
• Incentive Compensation: Confirm the sustainability of operating margins given the significant increase in incentive compensation accruals compared to the prior year.